And then finally, as I've sat back and I expressed to my board when I saw the accomplishments for this year, our telemedicine platform that I'm sure you're familiar with Cybersight has grown tremendously. I see more opportunity for us as we go ahead. And then, about probably a month ago now, at the end of October and beginning of November, we did a training I'm particularly proud of where we went to Doha, in Qatar, and we did a training for women, ophthalmologist and nurses from conflict zones. The first one we did in Texas at the Alcon campus with residents and students, We then held a training in California in coordination with UC Davis and Moffett Field for residents from Bolivia, Chile and Peru. And for us, we did three simulation trainings this year. You know, also, for me, 2022 was remarkable in that we were able to finally get back to some in person training, which was fabulous. And this plan is really focused on making sure that we are doing all that we can to link eye health to the sustainable development goals as stated by the UN. And so we're celebrating that, you know, I'm also delighted as the new CEO, I came on in September of 2020, that this year, we launched our new 5-year strategic plan. And that spirit of innovation that started us down that pathway is continued this year. It was 40 years ago, 1982, we had our first flying eye hospital visit to Panama. First, let’s talk about 2022 and the key developments for Orbis, including the return to in-person training.ĭerek Hodkey: Yeah, so for me, Dave, 2022 has been a remarkable year. This transcript has been edited for clarity:ĭavid Hutton: I am David Hutton of Ophthalmology Times.® I am joined today by Derek Hodkey, president and CEO of Orbis International.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |